CA1228546A - Oral mopidamol preparations - Google Patents

Oral mopidamol preparations

Info

Publication number
CA1228546A
CA1228546A CA000438670A CA438670A CA1228546A CA 1228546 A CA1228546 A CA 1228546A CA 000438670 A CA000438670 A CA 000438670A CA 438670 A CA438670 A CA 438670A CA 1228546 A CA1228546 A CA 1228546A
Authority
CA
Canada
Prior art keywords
mopidamol
pharmaceutical preparation
mixture
pellets
excipients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000438670A
Other languages
English (en)
French (fr)
Inventor
Gottfried Schepky
Rolf Brickl
Peter Gruber
Jochen Schmid
Ursula Springmeier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of CA1228546A publication Critical patent/CA1228546A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
CA000438670A 1982-10-09 1983-10-07 Oral mopidamol preparations Expired CA1228546A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3237575.1 1982-10-09
DE19823237575 DE3237575A1 (de) 1982-10-09 1982-10-09 Neue orale mopidamolformen

Publications (1)

Publication Number Publication Date
CA1228546A true CA1228546A (en) 1987-10-27

Family

ID=6175408

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000438670A Expired CA1228546A (en) 1982-10-09 1983-10-07 Oral mopidamol preparations

Country Status (18)

Country Link
US (2) US4596705A (enExample)
EP (1) EP0108898B1 (enExample)
JP (1) JPH07558B2 (enExample)
AT (1) ATE21481T1 (enExample)
AU (1) AU560251B2 (enExample)
CA (1) CA1228546A (enExample)
DE (2) DE3237575A1 (enExample)
DK (1) DK158541C (enExample)
ES (1) ES8500743A1 (enExample)
FI (1) FI79650C (enExample)
GB (1) GB2128088B (enExample)
GR (1) GR79015B (enExample)
IE (1) IE56058B1 (enExample)
IL (1) IL69930A (enExample)
NO (1) NO833638L (enExample)
NZ (1) NZ205894A (enExample)
PT (1) PT77467B (enExample)
ZA (1) ZA837499B (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3237575A1 (de) * 1982-10-09 1984-04-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale mopidamolformen
GB8414220D0 (en) * 1984-06-04 1984-07-11 Sterwin Ag Medicaments in unit dose form
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
CA1323833C (en) * 1987-04-28 1993-11-02 Yatindra M. Joshi Pharmaceutical compositions in the form of beadlets and method
US5364646A (en) * 1990-01-10 1994-11-15 Dr. Karl Thomae Gmbh Oral pharmaceutical forms of pimobendan
CA2039742A1 (en) * 1990-04-23 1991-10-24 Andrew B. Dennis Tablet composition and method for problem pharmaceutical materials
US5156845A (en) * 1990-05-04 1992-10-20 Colgate-Palmolive Company Dry mouth lozenge
US5523289A (en) * 1991-04-15 1996-06-04 Abbott Laboratories Pharmaceutical composition
WO1992020326A1 (en) * 1991-05-20 1992-11-26 Marion Laboratories, Inc. Multi-layered controlled release formulation
EP1093814A1 (en) * 1999-10-22 2001-04-25 Boehringer Ingelheim Pharma KG Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders
MXPA02008403A (es) * 2000-02-28 2004-09-27 Vectura Ltd Mejoras en o relacionadas con el suministro de farmacos por via oral.
US7064130B2 (en) * 2001-04-20 2006-06-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders
US20030181488A1 (en) 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
WO2004050068A1 (en) * 2002-11-29 2004-06-17 Janssen Pharmaceutica N.V. Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
CN1747734A (zh) * 2003-02-07 2006-03-15 贝林格尔·英格海姆国际有限公司 潘生丁或单哌潘生丁在治疗和预防mmp－9－依赖性疾病中的用途
CN1812792A (zh) 2003-04-24 2006-08-02 贝林格尔.英格海姆国际有限公司 双嘧达莫或单哌潘生丁用于治疗和预防凝血酶过量产生和/或凝血酶受体表达增加引起的血栓栓塞疾病和紊乱
CA2536401C (en) * 2003-11-04 2011-08-30 Shire Laboratories Inc. Compositions of quaternary ammonium compounds containing bioavailability enhancers
EP2210605B1 (en) * 2003-11-04 2017-03-01 TCD Royalty Sub, LLC Once daily dosage forms of trospium
DE102004011512B4 (de) * 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
US9205054B2 (en) 2005-03-22 2015-12-08 Losan Pharma Gmbh Solubilized ibuprofen
EP1915137B8 (de) 2005-08-10 2013-09-11 ADD Advanced Drug Delivery Technologies, Ltd. Orales präparat mit kontrollierter freisetzung
ES2531215T3 (es) * 2006-01-27 2015-03-11 Aptalis Pharmatech Inc Sistemas de administración de fármacos que comprenden un agente de bloqueo selectivo de la serotonina 5-HT3 débilmente básico y ácidos orgánicos
CA2640382C (en) * 2006-01-27 2015-12-29 Eurand, Inc Drug delivery systems comprising weakly basic drugs and organic acids
US7731604B2 (en) * 2006-10-31 2010-06-08 Taylor Made Golf Company, Inc. Golf club iron head
EP1920785A1 (en) * 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
UA97813C2 (uk) * 2006-12-05 2012-03-26 Янссен Фармацевтика Н.В. Фумаратна сіль (альфа s, бета r)-6-бром-альфа-[2-(диметиламіно)етил]-2-метоксі-альфа-1-нафталеніл-бета-феніл-3-хінолінетанолу
US8133506B2 (en) * 2008-03-12 2012-03-13 Aptalis Pharmatech, Inc. Drug delivery systems comprising weakly basic drugs and organic acids
WO2010060874A1 (en) 2008-11-25 2010-06-03 Boehringer Ingelheim Vetmedica Gmbh Phosphodiesterase type iii (pde iii) inhibitors or ca2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy
US20110003005A1 (en) * 2009-07-06 2011-01-06 Gopi Venkatesh Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions
ES2924478T3 (es) 2012-03-15 2022-10-07 Boehringer Ingelheim Vetmedica Gmbh Formulación de comprimidos farmacéuticos para el sector médico veterinario, método de producción y uso de los mismos
EP2898886B1 (en) 2012-09-19 2017-02-15 Taiho Pharmaceutical Co., Ltd. Pharmaceutical composition for oral administration with improved elution and/or absorbency
JP6272475B2 (ja) 2013-07-19 2018-01-31 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハーＢｏｅｈｒｉｎｇｅｒ Ｉｎｇｅｌｈｅｉｍ Ｖｅｔｍｅｄｉｃａ ＧｍｂＨ 防腐エーテル化シクロデキストリン誘導体含有液体水性医薬組成物
CN110721164B (zh) 2013-12-04 2024-09-17 勃林格殷格翰动物保健有限公司 匹莫苯的改善的药物组合物
JP6525897B2 (ja) * 2016-01-21 2019-06-05 日清オイリオグループ株式会社 タブレットの硬度調整剤
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
CN109942445A (zh) * 2019-02-26 2019-06-28 山东瑞弘生物科技有限公司 甜菜碱盐酸盐合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3322755A (en) 1964-03-10 1967-05-30 Boehringer Sohn Ingelheim Basic-substituted 1, 2, 3, 4-tetrahydropyrimido [5, 4-d]-pyrimidines
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
EP0019586A1 (de) * 1979-05-11 1980-11-26 Ciba-Geigy Ag Neue antithrombotische Kombinationspräparate
DE2931573A1 (de) * 1979-08-03 1981-02-26 Thomae Gmbh Dr K Mittel zur bekaempfung des wachstums von krebszellen und dessen herstellung
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
DE3126703A1 (de) * 1981-07-07 1983-01-27 Dr. Karl Thomae Gmbh, 7950 Biberach Bromhexin-retardform und verfahren zu ihrer herstellung
DE3237575A1 (de) * 1982-10-09 1984-04-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale mopidamolformen

Also Published As

Publication number Publication date
NZ205894A (en) 1986-08-08
GB2128088B (en) 1986-04-30
DE3237575A1 (de) 1984-04-12
DK460683A (da) 1984-04-10
EP0108898A1 (de) 1984-05-23
IL69930A0 (en) 1984-01-31
NO833638L (no) 1984-04-10
US4596705A (en) 1986-06-24
EP0108898B1 (de) 1986-08-20
ATE21481T1 (de) 1986-09-15
ZA837499B (en) 1985-06-26
GR79015B (enExample) 1984-10-02
JPH07558B2 (ja) 1995-01-11
IE56058B1 (en) 1991-04-10
FI833605A0 (fi) 1983-10-05
GB2128088A (en) 1984-04-26
FI833605L (fi) 1984-04-10
IL69930A (en) 1986-08-31
DK460683D0 (da) 1983-10-06
AU560251B2 (en) 1987-04-02
PT77467B (de) 1986-05-07
FI79650C (fi) 1990-02-12
DE3365465D1 (en) 1986-09-25
FI79650B (fi) 1989-10-31
US4650664A (en) 1987-03-17
GB8326877D0 (en) 1983-11-09
PT77467A (de) 1983-11-01
DK158541B (da) 1990-06-05
AU1998583A (en) 1984-04-12
ES526331A0 (es) 1984-11-01
IE832358L (en) 1984-04-09
ES8500743A1 (es) 1984-11-01
JPS5989615A (ja) 1984-05-23
DK158541C (da) 1990-11-05

Similar Documents

Publication Publication Date Title
CA1228546A (en) Oral mopidamol preparations
KR880001090B1 (ko) 디피리다몰의 경구용 제형의 제조방법
KR880001753B1 (ko) 브롬헥신 서방출성 제형의 제조방법
EP0305051B1 (en) Orally sustained-release acetaminophen formulation and process to obtain it
CA1255223A (en) Pellet formulation
KR100223131B1 (ko) 서방성 약제 용량 단위
US7976869B2 (en) Fenofibrate tablets
KR100421347B1 (ko) 약학 혼합 제제
JP2599189B2 (ja) 味覚遮蔽剤を含有している咀嚼可能な薬物錠剤
CA2426811A1 (en) Novel formulations of carvedilol
PL192648B1 (pl) Preparat farmaceutyczny o kontrolowanym uwalnianiu, zawierający inhibitor ACE jako substancję aktywną
CA2309542A1 (en) Novel oral dosage form for carvedilol
HK129894A (en) Tablet and granulate containing mesna as active agent
US4863741A (en) Tablet composition for drug combinations
WO1998005306A1 (en) Controlled release tablet formulation of isosorbide-5-mononitrate
WO1997025028A1 (en) Pharmaceutical controlled release beads comprising furosemide and a formulation containing said controlled release beads
HU191542B (en) Process for production of pastiles containing dipyridamel independent from ph with regulated output of the active substance
JPS61221116A (ja) 錠剤の組成物
KR840000692B1 (ko) 디피리다몰 서방출형 제제의 제조방법
IE970563A1 (en) A composition

Legal Events

Date Code Title Description
MKEX Expiry